A surrogate endpoint-based provisional approval causal roadmap, illustrated by vaccine development

Biostatistics · Published 2024-12-31 · DOI 10.1093/biostatistics/kxaf018

Authors being retrieved — see the publisher record. https://doi.org/10.1093/biostatistics/kxaf018

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2024

Related articles

• A two-stage approach for segmenting spatial point patterns applied to multiplex imaging · Biostatistics · 2025 · Same journal
• NBSR: a Negative Binomial Softmax Regression model for microRNA-seq data analysis · Biostatistics · 2026 · Same journal
• Towards optimal environmental policies: policy learning under arbitrary bipartite network interference · Biostatistics · 2025 · Same journal
• Semiparametric efficient estimation of small genetic effects in large-scale population cohorts · Biostatistics · 2024 · Same journal
• SAM-HC: a Bayesian nonparametric construction of hybrid control for randomized clinical trials using external data · Biostatistics · 2026 · Same journal
• Joint modeling of high-dimensional longitudinal data and survival using supervised low-rank tensor decomposition · Biostatistics · 2026 · Same journal
• Mediation with External Summary Statistic Information · Biostatistics · 2024 · Same journal
• Decomposition of longitudinal disparities: an application to the fetal growth-singletons study · Biostatistics · 2024 · Same journal
• Assessing treatment efficacy for interval-censored endpoints using multistate semi-Markov models fit to multiple data streams · Biostatistics · 2024 · Same journal
• Meta-analysis models with group structure for pleiotropy detection at gene and variant level using summary statistics from multiple datasets · Biostatistics · 2024 · Same journal